Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews
Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews
Background
Many systematic reviews exist on the use of remote patient monitoring (RPM) interventions to improve clinical outcomes and psychological well-being of patients with heart failure. However, research is broadly distributed from simple telephone-based to complex technology-based interventions. The scope and focus of such evidence also vary widely, creating challenges for clinicians who seek information on the effect of RPM interventions
Objective
The aim of this study was to investigate the effects of RPM interventions on the health outcomes of patients with heart failure by synthesizing review-level evidence.
Results
A total of 19 systematic reviews met our inclusion criteria. Reviews consisted of RPM with diverse interventions such as telemonitoring, home telehealth, mobile phone–based monitoring, and videoconferencing. All-cause mortality and heart failure mortality were the most frequently reported outcomes, but others such as quality of life, rehospitalization, emergency department visits, and length of stay were also reported. Self-care and knowledge were less commonly identified.
Conclusions
Telemonitoring and home telehealth appear generally effective in reducing heart failure rehospitalization and mortality. Other interventions, including the use of mobile phone–based monitoring and videoconferencing, require further investigation.
Congress Moves the Chess Pieces
Politico | October 28, 2016
Excerpt:
Krista Drobac, of the Alliance for Connected Care, also shared tempered enthusiasm about a “great first step” given the constraints Senate Finance staff faced. She vowed to bring more information on savings — we’re assuming this is another reference to the CBO-inspired budget doubts about telemedicine.
Telemonitoring Reduced Costs and Inpatient Visitation Rates for Patients with Advanced Cardiovascular Disease: A Matched Cohort Study Telemonitoring Reduced Costs and in-Patient Visitation Rates for Patients with Advanced Cardiovascularddisease
Introduction: Reducing the cost of care of patients with cardiovascular disease is an important target for integrated health systems. Managing these patients is difficult and costly, with commensurately high rates of inpatient (IP) visitation.
Hypothesis: Medical costs and IP visitation rates of patients receiving remote telemonitoring (TM) will decrease, relative to what they would have otherwise been.
Methods: We performed a concurrent matched cohort study, comparing patients receiving TM to those who did not. Our treatment cohort includes all members of Priority Health, Grand Rapids, MI (PH) that received TM between January 2012 and September 2013. Members of the treatment cohort were matched 1:1 against non-TM members of PH, indexed on the month of TM enrollment. Matching criteria includes age and sex; chronic morbidity status (heart failure, COPD, HTN, diabetes); observed medical costs 12 and 6 months prior to initiation of TM; and IP utilization within 12 months prior to initiation of TM. Members were excluded from treatment and putative control cohorts if they did not have continuous enrollment for 12 months prior and 24 months post initiation of TM. Endpoints include 24 month cumulative medical cost and IP visitations.
Results: We provide population-level metrics (Table) with 80% confidence intervals for endpoint differences and average cumulative cost and inpatient visitation curves (Figure) for our treatment and matched control cohorts.
Conclusions: Remote telemonitoring of patients with advanced cardiovascular disease can reduce inpatientvisitation rates, driving a reduction in medical costs. In this study, we estimate a visitation rate reduction of 4.9%, and a medical cost reduction of $13,608 over 24 months.
Firms push to revise telemedicine law
ArkansasOnline | June 24, 2016
Excerpt:
The forum was moderated by Krista Drobac, director of the Alliance for Connected Care, a Washington, D.C., group that advocates for coverage of telemedicine by Medicare, Medicaid and private insurers.
Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials
Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials
Aims: To assess the overall effect of telemedicine on diabetes management and to identify features of telemedicine interventions that are associated with better diabetes management outcomes.
Methods: Hedges’s g was estimated as the summary measure of mean difference in HbA1c between patients with diabetes who went through telemedicine care and those who went through conventional, non-telemedicine care using a random-effects model. Q statistics were calculated to assess if the effect of telemedicine on diabetes management differs by types of diabetes, age groups of patients, duration of intervention, and primary telemedicine approaches used.
Results: The analysis included 55 randomized controlled trials with a total of 9258 patients with diabetes, out of which 4607 were randomized to telemedicine groups and 4651 to conventional, non-telemedicine care groups. The results favored telemedicine over conventional care (Hedges’s g=-0.48, p<0.001) in diabetes management. The beneficial effect of telemedicine were more pronounced among patients with type 2 diabetes (Hedges’s g=-0.63, p<0.001) than among those with type 1 diabetes (Hedges’s g=-0.27, p=0.027) (Q=4.25, p=0.04).
Conclusions: Compared to conventional care, telemedicine is more effective in improving treatment outcomes for diabetes patients, especially for those with type 2 diabetes.
Finally, a Chance for Telemedicine to Shine in Medicare and Medicaid
This past week was big for telemedicine in public programs. Both telehealth and remote patient monitoring (RPM) are proven tools in the commercial marketplace, but reimbursement restrictions have made adoption in Medicare and Medicaid pretty close to non-existent. It is still essential to pass legislation to fix outdated legal barriers in these programs. However, the Center for Medicare and Medicaid Services (CMS) created opportunities this week to demonstrate how valuable telehealth and RPM can be to the health care of millions of seniors and low-income Americans.
In the commercial market, telehealth is used for convenience and after-hours care that can substitute for more expensive and time consuming in-person options. To date, RPM has largely been used to avoid hospital re-admissions and improve chronic disease management. The new rules and programs released by CMS open the door to showing how these tools can help achieve the important goals of patient engagement, care coordination, expanded access to care and population health management driven by primary care providers.
Door #1: Comprehensive Primary Care + model (CPC+). This alternative payment model is aimed at supporting primary care practitioners in delivering “advanced” primary care. It is a multi-payer initiative that will impact up to 3.5 million Medicare FFS beneficiaries, as well as millions of other Medicare Advantage, Medicaid, and commercial patients.
Primary care practitioners will be paid a non-visit based, risk-adjusted per beneficiary per month (PBPM) care management fee to help ensure services are “accessible, responsive to an individual’s preference, and patients can take advantage of enhanced in-person hours and 24/7 telephone or electronic access.”
Practices must also ensure that care is “coordinated across the health care system,” patients receive “timely” follow-up after emergency room or hospital visits and that care is “patient-centered.” Telemedicine achieves all of these goals. Since primary care practices will receive a care management fee, they have flexibility on where they can make their investments. That funding won’t be subject to the legal restrictions around telehealth or the lack of payment for RPM.
Door #2: Medicaid and CHIP Managed Care Rule. The final rule allows telemedicine to be used to meet network adequacy requirements in Medicaid. Before this rule, Medicaid managed care network adequacy regulation relied heavily on attestations and certifications from states. Now, states will have to develop time and distance standards and hold managed care plans accountable. Given how difficult it can be to find medical practitioners willing to accept Medicaid, telemedicine will be important to ensuring compliance with network adequacy.
Door #3: Medicare and CHIP Access and Re-authorization Act (MACRA) proposed rule. CMS moves physicians, nurses and other practitioners into value-based care by measuring care in four categories– quality, cost (new resource use), clinical practice improvement activities, and advancing care information (new meaningful use). The alternative is moving into an “advanced alternative payment model.” Telehealth figures prominently in assisting practitioners fulfill clinical practice improvement activities. It is mentioned explicitly as a way to expand practice access and manage patients who receive the drug warfarin. The tools can also apply in meeting practice improvement activities in the population management, patient engagement and care coordination categories. Also, telehealth services are categorized as “patient facing.”
The possibilities for more adoption in Medicare and Medicaid through these avenues is exciting. However, billing for telehealth and RPM services in Medicare and Medicaid remains difficult. We still need legislation to update the statute governing the these programs, but CMS’s efforts using existing authority are a step in the right direction.